Jonathan Schapiro
MD
National Hemophilia Center, Sheba Medical Center, Israel
This 60-minute symposium aims to address current challenges in HIV drug resistance and treatment optimization, with a specific focus on the evolving needs within North America.
The program will provide healthcare professionals and researchers with the latest scientific insights and practical strategies tailored to the American clinical landscape, while also integrating key international updates to ensure a globally informed perspective.
By deepening understanding of resistance mechanisms, therapeutic decision-making, and switching strategies in virologically suppressed patients, the symposium will empower participants to improve clinical outcomes and advance research-driven care in HIV management.
MD
National Hemophilia Center, Sheba Medical Center, Israel
magda.sevlidou@amededu.com